- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01319786
Effect of a Polyphenol Rich Diet on Vascular and Platelet Function (PPhIT)
Effect of a Polyphenol Rich Diet on Vascular and Platelet Function- a Randomised Control Trial
Previous work has shown that increasing fruit and vegetable intake in patients with high blood pressure improves cardiovascular function. Research indicates that this may be partly owing to compounds called polyphenols, which are found in abundance in fruits and vegetables and other foods such as wine, tea and dark chocolate. The investigators now wish to test if consuming fruits and vegetables (including berries which are very rich in polyphenols), as well as dark chocolate, has further benefits for cardiovascular function. A total of 110 subjects with high blood pressure will be recruited and asked to follow a low polyphenol diet (2 portions of fruit and vegetables daily and no berries or dark chocolate) for four weeks (a washout period). They will then be randomised to continue this diet or to consume 6 portions of fruits and vegetables (to include 1 portion berries) and 1 portion of dark chocolate daily for 8 weeks. The fruit, vegetables and dark chocolate will be provided free of charge and delivered to the homes of the participants who are randomised to the high fruit and vegetable arm of the study.
Assessment of microvascular and platelet function will be undertaken before and after consuming this diet. Improvements in these tests of cardiovascular function have previously been linked to reduced risks of heart disease in people with high blood pressure. This study will provide evidence as to whether or not a polyphenol rich diet can reduce the risk of developing heart disease.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Belfast, United Kingdom, BT12 6BJ
- Belfast Health and Social Care Trust
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 40-65 years old
- Systolic blood pressure 140-179 mmHg or diastolic blood pressure 90-109 mmHg
Exclusion Criteria:
- diabetes mellitus
- an acute coronary syndrome or transient ischaemic attack within the past 3 months
- special dietary requirements, food sensitivities or vegetarian/vegan diet by choice
- oral anticoagulation therapy
- body mass index greater than 35kg/m2
- excessive alcohol consumption (defined as > 28 units/week in men and 21 units/week in women)
- fasting triglyceride concentration > 4 mmol/l
- pregnancy/lactation
- taking antioxidant supplements
- medical conditions or dietary restrictions that would substantially limit ability to complete the study requirements
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Low- polyphenol diet
|
Two portions of fruit and vegetables per day (excluding berries and dark chocolate)
|
Active Comparator: High-polyphenol diet
|
Six portions of fruit and vegetables per day (one of which must be berries) and 50g dark chocolate.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Vascular function
Time Frame: Measured at weeks 4 and 12
|
Pharmacological provocation of endothelium-dependent vasomotion.
|
Measured at weeks 4 and 12
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Platelet function, biomarkers of cardiovascular risk and heart rate variability
Time Frame: Measured at weeks 0, 4 and 12
|
Measured at weeks 0, 4 and 12
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Pascal McKeown, MD, Belfast Health and Social Care Trust
- Study Director: Jayne Woodside, PhD, Queen's University, Belfast
- Study Director: Michelle McKinley, PhD, Queen's University, Belfast
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- QueensUBelfast
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Addpharma Inc.Completed
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical SciencesCompletedHypertension, Resistant to Conventional Therapy | Primary HypertensionChina
-
Cytos Biotechnology AGCompletedMild Essential Hypertension | Moderate Essential HypertensionSwitzerland
Clinical Trials on Two portions of fruit and vegetables per day (excluding berries and dark chocolate)
-
Queen's University, BelfastCompletedHealthyUnited Kingdom
-
Queen's University, BelfastCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Swiss Federal Institute of TechnologyCompletedAnemia | Iron Deficiency Anemia | Iron DeficiencySwitzerland
-
International Centre for Diarrhoeal Disease Research...Karolinska InstitutetCompletedTesting Effect of Intervention
-
University Hospital, LilleCelgene CorporationCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCTerminatedAdenomatous Polyposis Coli
-
Combined Military Hospital QuettaRecruitingVestibular Disorder PreservationPakistan
-
Memorial Sloan Kettering Cancer CenterCompletedAcute Myeloid Leukemia | Advanced Myelodysplastic SyndromesUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveGermany, Netherlands, Denmark, France, South Africa, Austria, Belgium, Sweden